Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
Symmetry Medical Inc. (SMA)
|
Add to portfolio |
|
|
|
| Price: |
$8200.00
| | Metrics |
| OS: |
37.6
|
M
| |
-2
|
% ROE
|
| Market cap: |
$308
|
B
| |
12
|
% ROIC
|
|
Net debt:
|
$144
|
M
| |
3.3
|
x Debt/EBITDA
|
|
EV:
|
$308
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$43.3
|
M
| |
7119.0
|
x EV/EBITDA
|
|
EBIT
|
$23.6
|
M
| |
13030.2
|
x EV/EBIT
|
| EPS |
($0.06)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-28-13 | Dec-29-12 | Dec-31-11 | Jan-01-11 | Jan-02-10 | Jan-03-09 | Dec-29-07 | Jan-03-07 |
| Revenues | 400.0 | 410.5 | 359.0 | 360.8 | 365.9 | | 290.9 | 423.4 |
| Revenue growth | -2.6% | 14.3% | -0.5% | -1.4% | | | 18.7% | 63.0% |
| Cost of goods sold | 297.9 | 301.4 | 287.9 | 281.1 | 278.9 | | 238.3 | 323.0 |
| Gross profit | 102.1 | 109.1 | 71.1 | 79.7 | 87.0 | | 52.6 | 100.4 |
| Gross margin | 25.5% | 26.6% | 19.8% | 22.1% | 23.8% | | 18.1% | 23.7% |
| Selling, general and administrative | | | | | 47.9 | | 39.5 | 58.3 |
| Sales and marketing | 26.0 | 26.4 | 17.5 | 17.9 | | | | |
| Research and development | 4.6 | 4.2 | 4.0 | 3.4 | | | | |
| General and administrative | 46.3 | 44.9 | 37.2 | 29.2 | | | | |
| EBITA | 30.8 | 41.1 | 12.7 | 31.1 | 39.3 | | 13.1 | 42.0 |
| EBITA margin | 7.7% | 10.0% | 3.5% | 8.6% | 10.7% | | 4.5% | 9.9% |
| Amortization of intangibles | 7.2 | 8.0 | 2.9 | 2.9 | 2.9 | | | |
| EBIT | 23.6 | 33.0 | 9.8 | 28.2 | 36.3 | | 13.1 | 42.0 |
| EBIT margin | 5.9% | 8.0% | 2.7% | 7.8% | 9.9% | | 4.5% | 9.9% |
| Pre-tax income | -52.4 | 13.8 | 4.0 | 21.9 | 30.4 | | 4.9 | 31.5 |
| Income taxes | -16.6 | 4.6 | 1.1 | 7.9 | 8.6 | | 5.1 | 7.5 |
| Tax rate | 31.7% | 33.7% | 27.5% | 36.2% | 28.4% | | 103.0% | 23.8% |
| Net income | -35.8 | 9.1 | 2.9 | 14.0 | 21.8 | | -0.1 | 24.0 |
| Net margin | -8.9% | 2.2% | 0.8% | 3.9% | 6.0% | | -0.1% | 5.7% |
| |
| Diluted EPS | ($0.99) | $0.25 | $0.08 | $0.39 | $0.61 | | $0.00 | $0.68 |
| Shares outstanding (diluted) | 36.3 | 36.4 | 36.0 | 35.8 | 35.5 | | 35.3 | 35.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|